What is the latest Akebia Therapeutics (AKBA) news?

MoveSurge Every market-moving story. Fast. Clear. Complete.

Go real time Sign In

Never miss the news that moves markets. Protecting traders and investors since 2006. Every market-moving story. Fast. Clear. Complete. Wide coverage Global markets and U.S. stocks of every size. Fast Important news reaches you as it breaks. Clear Plain words and extra context only when you need it.

Analyst-led coverage since 2006 Covers: Global markets, all sizes of U.S. stocks, central banks, economic data, politics, oil, gold, and more. Direct sources included

Akebia Therapeutics (AKBA) News Today

No Akebia Therapeutics (AKBA) headline in the last 7 days came with a measured price move.

Why Akebia Therapeutics (AKBA) moved: the full explanation

Every AKBA headline we timestamp, with the price move measured one minute after we published it and at the end of the measured window.

What moved AKBA — last 7 days

No AKBA headline has appeared in our news feed with a measured price move in the last 7 days. This page fills automatically the next time one does.

Our analysis

Why Was Akebia Therapeutics Stock Down on Aug 5, 2026?

Wednesday, Aug 5, 2026 · Akebia beat Q2 2026 estimates as its newer drug Vafseo kept growing, even as total revenue fell year-over-year because its older drug Auryxia lost ground to …

Related coverage

The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources

Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.